We found that both adenocarcinoma (Adc) and lung squamous cell carcinoma (SCC) have aberrant expression of MAL2. It was upregulated in 10.54% of Adc cases and in 4.49% of SCC cases (Fig. 1A, B). Here, MAL2 is linked to squamous cell lung carcinoma.